Skip to content

What do benzos increase? Unpacking the effects on GABA, dopamine, and the central nervous system

4 min read

Benzodiazepines, a class of drugs that includes Xanax and Valium, are among the most commonly prescribed medications in the United States, and understanding their mechanism of action is crucial. What do benzos increase to produce their sedative and anxiolytic effects, and what are the potential risks involved? The answer lies in their powerful impact on the brain's most important chemical messengers.

Quick Summary

Benzodiazepines amplify the effects of the inhibitory neurotransmitter GABA, calming the central nervous system. This action can also indirectly increase dopamine levels in reward circuits, a factor in their addictive potential. Chronic use leads to tolerance and dependence.

Key Points

  • GABA Potentiation: Benzos act as positive allosteric modulators on GABA-A receptors, significantly increasing GABA's inhibitory effect throughout the central nervous system.

  • Dopamine Increase: Benzos indirectly increase dopamine levels in the brain's reward pathways by suppressing inhibitory GABAergic interneurons, a process known as disinhibition.

  • Calming Effects: The increased GABAergic inhibition leads to the therapeutic effects of benzos, including reduced anxiety, sedation, muscle relaxation, and anticonvulsant properties.

  • Addictive Potential: The secondary increase in dopamine creates pleasurable sensations that reinforce drug use and contribute to the potential for addiction.

  • Increased Risks: With chronic use, benzos increase the risk of tolerance, physical dependence, cognitive impairment, and severe withdrawal symptoms, including seizures.

  • Overdose Risk: Mixing benzos with other CNS depressants, particularly alcohol and opioids, dramatically increases the risk of life-threatening respiratory depression.

In This Article

The Primary Effect: Boosting the Brain's Brake Pedal

At the core of benzodiazepines' effects is their action on the gamma-aminobutyric acid, or GABA, system. Often described as the brain's "brake pedal," GABA is the chief inhibitory neurotransmitter in the central nervous system (CNS). Its role is to reduce neuronal excitability, essentially slowing down nerve impulses to produce a calming effect.

Benzodiazepines do not directly activate GABA receptors, but rather act as positive allosteric modulators on GABA-A receptors. This means they bind to a specific site on the receptor that is different from where GABA binds. When a benzo is attached, it causes a conformational change that increases the GABA-A receptor's efficiency. This enhanced function results in more chloride ions entering the neuron, making it more resistant to excitation. The overall result is a potentiation of GABA's natural inhibitory effects, leading to the anxiolytic, sedative, muscle-relaxant, and anticonvulsant properties for which benzos are prescribed.

The Resulting Increase in Inhibition

This amplified inhibitory effect across the brain and spinal cord manifests in several clinical outcomes:

  • Anxiety Relief: By calming overactive neural circuits, benzodiazepines can reduce feelings of anxiety and panic.
  • Sedation: The widespread increase in inhibition leads to drowsiness and can induce sleep, which is why some benzos are used for insomnia.
  • Muscle Relaxation: Action on GABA receptors in the spinal cord contributes to their ability to relax muscles and treat spasms.
  • Amnesia: High-potency benzodiazepines can impair the formation of new memories, a desired effect in pre-surgical sedation but a negative side effect otherwise.

The Secondary Effect: Increasing Dopamine in Reward Circuits

While the main pharmacological effect is on GABA, benzodiazepines also cause a secondary, indirect increase in dopamine, the "feel-good" neurotransmitter associated with reward and pleasure. This is a key factor in their potential for misuse and addiction. The mechanism for this is rooted in the interplay between different neurons in the brain's reward pathway, specifically the ventral tegmental area (VTA) and the nucleus accumbens.

Instead of acting directly on dopamine neurons, benzos inhibit GABAergic interneurons that normally suppress the dopamine-producing neurons. This process is known as disinhibition. By removing the brake on these dopamine neurons, benzos allow them to fire more frequently, leading to an increase in dopamine release. This surge in dopamine is what creates a pleasurable or euphoric feeling, reinforcing the drug-taking behavior.

Potential Downsides: Increased Risks and Side Effects

The dual action of benzodiazepines comes with significant risks, especially with chronic use. Patients can develop tolerance, requiring higher doses to achieve the same effect. This can lead to physical dependence, where the body adapts to the drug and requires it to function normally. Abruptly stopping or reducing the dosage can cause severe and potentially life-threatening withdrawal symptoms, including seizures.

Mixing benzodiazepines with other central nervous system depressants, like alcohol or opioids, significantly increases the risk of respiratory depression, overdose, and death. The increase in GABA activity, combined with other sedative substances, can severely slow down breathing.

Long-term use is also associated with cognitive decline, memory problems, and an increased risk of falls, particularly in older adults. The paradoxical effect of increased agitation, aggression, and anxiety can also occur in some individuals.

Common Benzodiazepines and Their Primary Uses

Here is a list of some of the most commonly prescribed benzodiazepines and the conditions they typically treat:

  • Alprazolam (Xanax): Primarily for anxiety and panic disorders.
  • Diazepam (Valium): Used for anxiety, muscle spasms, and alcohol withdrawal.
  • Clonazepam (Klonopin): Prescribed for seizures and chronic anxiety.
  • Lorazepam (Ativan): Often used for acute anxiety, seizures, and pre-surgery sedation.
  • Temazepam (Restoril): Primarily used as a hypnotic for insomnia.

How Benzodiazepines Impact Brain Chemistry

Feature GABA Effect (Primary) Dopamine Effect (Secondary)
Mechanism Enhances GABA's binding efficiency at GABA-A receptors, increasing chloride ion influx. Disinhibits dopamine-releasing neurons by suppressing GABAergic interneurons.
Action on Neuron Hyperpolarizes neurons, making them less excitable and reducing nerve impulses. Leads to increased firing of dopamine neurons in the ventral tegmental area (VTA).
Psychological Effect Produces calming, anxiolytic, and sedative effects by reducing overall brain activity. Reinforces drug-taking behavior by creating a sense of pleasure or reward.
Associated Risk Can lead to physical dependence, tolerance, and withdrawal seizures upon discontinuation. Contributes to the potential for substance use disorder and addiction.

Conclusion

Benzodiazepines are powerful medications that primarily increase the inhibitory effects of GABA, slowing down the central nervous system to reduce anxiety, relax muscles, and induce sleep. However, this calming effect is accompanied by a secondary, indirect increase in dopamine activity in the brain's reward centers. This dual action explains both their therapeutic efficacy and their significant potential for tolerance, physical dependence, and addiction. Given these risks, benzodiazepines are generally recommended for short-term use only and should be taken under strict medical supervision. For individuals struggling with misuse, professional help is crucial due to the dangers of abrupt withdrawal. The intricate balance between the calming effects of GABA and the rewarding effects of dopamine underscores why these medications must be approached with caution. For more information on responsible benzodiazepine use and addiction, refer to resources from reputable medical authorities.

Frequently Asked Questions

Benzodiazepines primarily increase the effect of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), by making the GABA-A receptor more receptive to GABA's binding.

Benzodiazepines decrease overall brain activity. By increasing the inhibitory effect of GABA, they slow down nerve impulses throughout the central nervous system.

Benzodiazepines cause an indirect increase in dopamine by disinhibiting dopamine-releasing neurons in the brain's reward pathway. They suppress the inhibitory neurons that normally regulate dopamine levels, allowing dopamine to increase.

Long-term medication that increases GABA can lead to tolerance, physical dependence, cognitive impairment (such as memory problems), and severe withdrawal symptoms if stopped abruptly.

Tolerance to benzodiazepines, particularly to their sedative effects, can develop quite quickly, sometimes within a few days or weeks of regular use.

Rebound anxiety is an increase in anxiety symptoms that can occur when a person stops taking a benzodiazepine, sometimes even becoming worse than the original anxiety that was being treated.

Benzodiazepines are not recommended for long-term use due to the high risk of developing tolerance, physical and psychological dependence, and significant side effects such as cognitive impairment and memory loss.

Yes, it is extremely dangerous to mix benzodiazepines with alcohol. Both are central nervous system depressants, and their combined effect can lead to severe respiratory depression, overdose, and death.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.